News | February 11, 2019
MedPharm Ltd, is expanding its partnership with Palvella Therapeutics, Inc. MedPharm has employed its formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for...
News | April 19, 2019
Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic...
Contact Dermatitis (CD) is an inflammatory skin condition caused by reactivity to an extrinsic chemical agent. CD is the fifth most common dermatologic disease in American patients, and worldwide prevalence ranges from 12.5 to 40.6 percent,...
News | March 1, 2019
As more frequent and intense flooding disasters have occurred in conjunction with progressively rising temperatures, both disaster victims and relief workers have experienced significant dermatologic problems, according to new research...
News | April 8, 2019
La Roche-Posay brand is sponsoring a patient to travel to the Thermal Dermatology center in the town of La Roche-Posay, France this fall. With 8,000 visitors per year, a third of whom are children, the La Roche-Posay thermal center is...
Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapy
La Roche-Posay to Sponsor a Patient to Visit Thermal Dermatology Center: Accepting Nominations
Steroid DTH should be considered when an inflammatory skin disease continues to worsen despite use of topical corticosteroid.
Sharon E. Jacob, MD; and Jodie Raffi, BA
Though the relationship is not fully understood, it points the way to potential treatments.
Sara Noor Bilimoria; and Peter A. Lio, MD
Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Program
MedPharm Ltd. Expands Partnership with Palvella Therapeutics, Inc. for PC Treatment
Here's a handy reference to new drugs and devices—and other key developments—this year.
Access to newer medications remains a challenge in pediatric dermatology patients.
First-line treatment tips and a review of when to assess for an alternate diagnosis.
Janna M. Vassantachart, MD, Sharon E. Jacob, MD and Shehla Admani, M
Adherence to acne treatment regimens is notoriously low among pre-teens and adolescents. Here's how to change that.
Andrew C. Krakowski, MD, FAAD